Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2021

Next generation therapies in metastatic breast cancer  

New generation antibody drug conjugates (ADCs) 

Date

16 Sep 2021

Session

Next generation therapies in metastatic breast cancer  

Presenters

Ian Krop

Authors

I. Krop

Author affiliations

  • Medical Oncology Department, Dana Farber Cancer Institute, 02115 - Boston/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: Carlos Barrios

Session: Next generation therapies in metastatic breast cancer  

Resources:

Webcast

What comes after anti-PD1? 

Presenter: Giuseppe Curigliano

Session: Next generation therapies in metastatic breast cancer  

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.